Skip to content
Open access · CC-BY via OpenAlex

Time‐Restricted Eating to Improve Metabolic Abnormalities in Polycystic Ovarian Syndrome (TimeMAP)

Ruairí Floyd, Adam Dyer, James Gibney, Fatimah Alawami, Lisa Ann Owens, Niamh Phelan, Ana Rakovac, Patrick Swan, Carel Wynand le Roux, Lucy‐Ann Behan, Sinead Noelle Duggan

Clinical Endocrinology · 2026 · ▲ 4 citations

Abstract

OBJECTIVE: Time-restricted eating (TRE) represents a novel intervention that may improve hyperinsulinaemia and reduce weight, but has not been studied in polycystic ovarian syndrome (PCOS). In a randomised interventional study (NCT05126199 [1]), we investigated the feasibility of TRE in PCOS including recruitment, compliance, safety, drop-out rate, and effect on insulin-related parameters, anthropometrics, nutritional intake and metabolic indices. METHODS: Participants were randomised to a 12-week TRE regimen (18 h fast/6 h eating window) or 'ad libitum' regimen (no time-restriction), and then crossed over to the alternative regimen for a further 12 weeks. RESULTS: TRE was a feasible intervention with near-total compliance in those completing the intervention; however, there were considerable difficulties with recruitment. A total of 70 were eligible to participate, of which ultimately 15 were recruited, and 11 completed the study (4 [27%] drop-outs due to commitment/study duration). There were no serious adverse events in the TRE group. Compliance [%(SD)] with TRE was 94.7(4.5)%, and 10 participants were keen to continue the intervention post-study. Whilst the study was not powered to detect changes in metabolic or anthropometric indices, exploratory analysis showed a decrease in HbA1c (p = 0.04), weight (p = 0.001), BMI (p = 0.001), hip circumference (p = 0.05) and waist circumference (p = 0.001) in the TRE group compared to the ad libitum eating group. CONCLUSION: In a 12-week cross-over feasibility study, TRE was a safe and feasible intervention. Recruitment was challenging and with limited numbers, the TRE group showed a decrease in HbA1c and anthropometric indices compared to the 'ad libitum' group. TRIAL REGISTRATION: NCT05126199.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1111/cen.70094
Canonical
link ↗
Fetched
2026-11-07 MST

Cite this

APA
Floyd, R., Dyer, A., Gibney, J., Alawami, F., Owens, L.A., Phelan, N., Rakovac, A., Swan, P., Roux, C.W.L., Behan, L., &amp; Duggan, S.N. (2026). Time‐Restricted Eating to Improve Metabolic Abnormalities in Polycystic Ovarian Syndrome (TimeMAP). <em>Clinical Endocrinology</em>. https://doi.org/10.1111/cen.70094
Vancouver
Floyd R, Dyer A, Gibney J, Alawami F, Owens LA, Phelan N, et al. Time‐Restricted Eating to Improve Metabolic Abnormalities in Polycystic Ovarian Syndrome (TimeMAP). Clinical Endocrinology. 2026. doi:10.1111/cen.70094.
BibTeX
@article{ruair2026TimeRe, title = {Time‐Restricted Eating to Improve Metabolic Abnormalities in Polycystic Ovarian Syndrome (TimeMAP)}, author = {Ruairí Floyd and Adam Dyer and James Gibney and Fatimah Alawami and Lisa Ann Owens and Niamh Phelan and Ana Rakovac and Patrick Swan and Carel Wynand le Roux and Lucy‐Ann Behan and Sinead Noelle Duggan}, journal = {Clinical Endocrinology}, year = {2026}, doi = {10.1111/cen.70094}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings